Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
Blood
|
September 1, 1980
Impaired mononuclear cell tissue factor generation in patients with immunodeficiency diseases
M Ballow, F R Rickles
Archives of Neurology
|
February 1, 1993
Safety of intravenous immunoglobulin
C A Thornton, M Ballow
Clinical Immunology and Immunopathology
|
November 1, 1977
Combination immunotherapy in chronic mucocutaneous candidiasis. Synergism between transfer factor and fetal thymus tissue
M Ballow, L R Hyman
Cellular Immunology
|
October 1, 1981
In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse
M Ballow, A G Pantschenko
Cellular Immunology
|
October 1, 1975
Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor
M Ballow, R A Good
The New England Journal of Medicine
|
January 24, 1985
Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia
W B White, M Ballow
Journal of Clinical & Laboratory Immunology
|
October 1, 1984
Long-term T-cell lines from the tears of patients with vernal conjunctivitis
R B Clark, M Ballow
The Journal of Allergy and Clinical Immunology
|
October 1, 1989
Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin
M Ballow, W White, C Desbonnet
Clinical Immunology and Immunopathology
|
June 1, 1991
The effects of retinoic acid on immunoglobulin synthesis by human cord blood mononuclear cells
H Israel, C Odziemiec, M Ballow
Clinical Immunology and Immunopathology
|
September 1, 1996
Modulation of B-cell immunoglobulin synthesis by retinoic acid
M Ballow, W Wang, S Xiang
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
Blood
|
September 1, 1980
Impaired mononuclear cell tissue factor generation in patients with immunodeficiency diseases
M Ballow, F R Rickles
Archives of Neurology
|
February 1, 1993
Safety of intravenous immunoglobulin
C A Thornton, M Ballow
Clinical Immunology and Immunopathology
|
November 1, 1977
Combination immunotherapy in chronic mucocutaneous candidiasis. Synergism between transfer factor and fetal thymus tissue
M Ballow, L R Hyman
Cellular Immunology
|
October 1, 1981
In vitro effects of adenosine deaminase inhibitors on lymphocyte mitogen responsiveness in the mouse
M Ballow, A G Pantschenko
Cellular Immunology
|
October 1, 1975
Report of a patient with T-cell deficiency and normal B-cell function: a new immunodeficiency disease with response to transfer factor
M Ballow, R A Good
The New England Journal of Medicine
|
January 24, 1985
Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia
W B White, M Ballow
Journal of Clinical & Laboratory Immunology
|
October 1, 1984
Long-term T-cell lines from the tears of patients with vernal conjunctivitis
R B Clark, M Ballow
The Journal of Allergy and Clinical Immunology
|
October 1, 1989
Modulation of in vitro synthesis of immunoglobulin and the induction of suppressor activity by therapy with intravenous immune globulin
M Ballow, W White, C Desbonnet
Clinical Immunology and Immunopathology
|
June 1, 1991
The effects of retinoic acid on immunoglobulin synthesis by human cord blood mononuclear cells
H Israel, C Odziemiec, M Ballow
Clinical Immunology and Immunopathology
|
September 1, 1996
Modulation of B-cell immunoglobulin synthesis by retinoic acid
M Ballow, W Wang, S Xiang
Page
of 11